• SENSEX 76,024.51
    -1,390.41 (--1.80%)
  • BANKNIFTY 50,827.50
    -737.35 (--1.43%)
  • Vodafone Idea
    8.57 19.15(%)
  • Hind.Aeronautics
    4,492.80 5,675.00(%)
  • HBL Engineering
    532.15 738.65(%)
  • Reliance Industr
    1,250.00 1,156.00(%)
  • HDFC Bank
    1,765.00 1,430.15(%)
  • Galaxy Surfact.
    2,096.20 3,366.30(%)
  • Adani Green
    916.95 758.00(%)
  • ICICI Bank
    1,315.00 1,048.35(%)
  • Zomato Ltd
    205.00 304.50(%)
  • Larsen & Toubro
    3,430.60 3,141.30(%)
  • Infosys
    1,518.00 1,359.10(%)
  • Bajaj Finance
    8,672.00 6,376.55(%)
  • Dixon Technolog.
    12,880.05 7,100.05(%)
  • IndusInd Bank
    689.85 1,576.00(%)
  • ITC
    405.50 381.24(%)
  • Nip. India Gold
    77.05 77.05(%)
  • St Bk of India
    763.05 679.65(%)
  • M & M
    2,625.00 1,891.30(%)
  • Trent
    5,619.85 8,345.85(%)
  • PB Fintech.
    1,505.90 1,110.25(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Adline Chem Lab Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 5655.0
  • ISIN : INE276T01018
12.61 -1 (-4.90%)
  • As on 02 Apr 2025 (EOD)

  • Today’s Low

    12.61

  • Today’s High

    12.61

  • Open

    12.61

  • Perv Close

    13.26

  • 52W Low

    11.92

  • 52W High

    27.27

Key Indicators

  • P/E(TTM)

    0.00

  • Mar.Cap (₹Cr.)

    7.38

  • Div & Yield %

    0.00

  • Book Value(₹)

    -2.70

  • Debt-Equity Ratio

    -4.90

  • AGM Date

    01-Apr-2025

  • EPS

    0.00

  • P/E Ratio

    0.00

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    7.38

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    5.85

  • BV (₹)

    -2.70

  • Sales( ₹ in Cr.)

    0.00

  • NP (in Cr.)

    -0.15

  • NP Var(%)

    -232.0

  • Div%

    0.0

  • CPS (₹)

    -0.30

  • EPS (₹)

    -0.30

  • Traded Value (₹ in Lakhs)

    7.38

  • 52 Week High

    27.27

  • 52 Week Low

    11.92

  • Price BSE

    13.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    7.38

  • P/C Ratio

    -51.90

  • P/E Ratio

    -51.90

  • Price Vs.BV

    -0.30

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
Sales Turnover 0.00 0.00 0.74 6.33 6.59 5.59
Excise Duty 0.00 0.00 0.74 6.33 6.59 5.59
Net Sales 0.00 0.00 0.74 6.33 6.59 5.59
Other Income 0.03 1.00 0.18 0.00 0.02 0.25
Stock Adjustments 0.00 0.00 0.00 0.00 0.00 0.00
Total Income 0.03 1.00 0.92 6.33 6.61 5.84
EXPENDITURE :
Raw Materials 0.00 0.00 0.74 6.33 6.59 5.59
Power & Fuel Cost 0.00 0.00 0.74 6.33 6.59 5.59
Employee Cost 0.04 0.05 0.18 1.71 1.94 1.52
Other Manufacturing Expenses 0.01 0.42 0.12 0.60 1.50 0.99
Selling & Administrative Expenses 0.13 0.07 0.23 1.08 1.19 0.90
Miscellaneous Expenses 0.01 0.42 0.12 0.60 1.50 0.99
Less : Pre-operative Expenses Capitalised :
Total Expenditure 0.18 0.88 1.39 7.61 10.37 5.81
Operating Profit 0.00 0.00 0.01 0.13 0.41 0.17
Interest 0.00 0.00 0.01 0.03 0.02 0.07
Gross Profit -0.15 -4.23 0.67 -1.28 -3.51 0.03
Depreciation 0.00 0.09 0.35 1.02 0.42 0.73
Profit Before Tax -0.15 -4.23 0.67 -1.28 -3.51 0.03
Tax 0.00 0.00 0.00 0.00 0.25 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 -0.05 0.00 0.00 0.00
Reported Net Profit -0.15 -4.23 0.72 -1.28 -3.76 0.03
Extraordinary Items -0.15 -4.23 0.67 -1.28 -3.51 0.03
Adjusted Net Profit -0.15 -4.23 0.72 -1.28 -3.76 0.03
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 0.00 0.00 0.00 0.00 0.00 0.00
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down -0.15 -4.23 0.72 -1.28 -3.76 0.03
Dividend - - - - - -
Preference Dividend - - - - - -
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr -0.25 -7.24 1.23 -2.19 -6.45 0.05
Book Value 0.00 0.00 0.00 0.00 0.00 0.00
Book Value(Adj)-Unit Curr 0.00 0.00 0.00 0.00 0.00 0.00

Shareholding Pattern

  • Promoter Group

    29.61%

  • Public Share Holding

    70.39%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 1,732,240 29.61 1,512,440 9
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 1,732,240 29.61 1,512,440 9
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 0 0.00 0 0
2] Non Institution
Bodies Corporate 15,500 0.27 12,300 13
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 577,300 9.87 7,600 951
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 1,200 0.02 1,200 6
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 252,600 4.32 22,900 5
Individuals holding nominal share capital up to Rs. 1 lakh 3,266,160 55.83 281,500 17,524
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 4,117,760 70.39 330,500 18,500
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 5,850,000 100.00 1,842,940 18,509

Company Background

Adline Chem Lab LtdPharmaceuticals - Indian - Formulations

  • Adline Chem Lab Ltd
  • BSE Code : 5655.0
  • ISIN : INE276T01018

  • Incorporation Year

    1988

  • Registered Office

    904 9th Floor
    Shapath-I Complex S G Highway, Ahmedabad,
    Gujarat-382721

  • Telephone

    91-02764-286549/286559

  • FAX

    91-02764-286038

  • Chairman

  • Managing Director

    SARANG PATHAK

  • Company Secretary

    Ritu Singh

  • Auditor

    Deepak Soni & Associates/Jain Kedia & Sharma

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Link Intime India Pvt Ltd
    5th Floor 506 to 508,
    ABC-1 Off C.G Road ,Ellisbridge
    Mumbai - Ahmedabad-380006

Adline Chem Lab Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Adline Chem Lab 12.61 0.03 0.00 -19.40 0.00
Abbott India 30,305.85 6,097.18 5,848.91 48.26 44.71
Astrazeneca Phar 8,518.55 1,330.33 1,295.53 219.61 33.26
P & G Health Ltd 5,152.30 1,166.89 1,151.26 36.15 39.76
Glaxosmi. Pharma 2,793.40 3,530.73 3,407.25 55.55 44.44
Cipla 1,444.55 17,645.00 16,574.34 24.77 20.10
Amrutanjan Healt 642.85 437.58 421.23 37.68 20.84
Fermenta Biotec. 285.30 315.24 307.09 27.04 4.10
Guj. Themis Bio. 271.85 174.19 169.82 56.28 44.82
Bliss GVS Pharma 119.25 638.96 605.46 27.29 11.19
Ambalal Sarabhai 36.15 11.70 3.81 15.45 1.92